SAMANTHA DELORIMIER: Open Payments
NPI 1851708127 · MARGATE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,842 in 143 payments from 18 companies in 2025. Trend: 2023 $3,109 · 2024 $3,302 · 2025 $2,842
Food & beverage: $2,727Education: $115
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $464 |
| Regeneron Healthcare Solutions, Inc. | 19 | $373 |
| Janssen Biotech, Inc. | 11 | $328 |
| ABBVIE INC. | 21 | $290 |
| Incyte Corporation | 11 | $278 |
| Arcutis Biotherapeutics, Inc. | 16 | $161 |
| PFIZER INC. | 6 | $146 |
| Galderma Laboratories, L.P. | 13 | $144 |
| Lilly USA, LLC | 5 | $117 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $87 |
Products named: DUPIXENT, TREMFYA, OPZELURA, RINVOQ, Zoryve, CIBINQO, NEMLUVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
